We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Lexology logo






  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 26

Quick drug fix sought in the U.K.

  • Gowling Lafleur Henderson LLP
  • -
  • United Kingdom
  • -
  • January 17 2008

The National Institute for Health and Clinical Excellence (NICE) recently released a report in the U.K., which suggests that all new drugs should be assessed at launch with tougher initial cost hurdles for new drugs that are to be added to the state health service

Changes to UK Pharmaceutical Price Regulation Scheme now in effect

  • Gowling Lafleur Henderson LLP
  • -
  • United Kingdom
  • -
  • January 19 2009

A new Pharmaceutical Price Regulation Scheme (PPRS) came into effect in the U.K. on January 1, 2009

U.K. published new guidelines for early stage-clinical trials

  • Gowling Lafleur Henderson LLP
  • -
  • United Kingdom
  • -
  • August 24 2007

The Association of the British Pharmaceutical Industry (ABPI) has published new clinical testing guidelines

European Court of Justice health and safety ruling ”best possible” result for the U.K.

  • Gowling Lafleur Henderson LLP
  • -
  • European Union, United Kingdom
  • -
  • September 19 2007

A key decision in the European Court of Justice (“ECJ”), dated June 14, 2007, saw the U.K. win a significant law suit against the European Commission over its interpretation of health and safety legislation

NICE to launch an independent study of how to account for value in new health technologies

  • Gowling Lafleur Henderson LLP
  • -
  • United Kingdom
  • -
  • February 9 2009

The National Institute of Health and Clinical Excellence (NICE), the United Kingdom's independent organisation responsible for providing guidance on health promotion and treatment of ill health, has confirmed that it is undertaking a study of how value is accounted for when assessing new health technologies

UK advances in stem cell research law

  • Gowling Lafleur Henderson LLP
  • -
  • United Kingdom
  • -
  • October 30 2008

Britain's House of Commons voted 355 to 129 on a complete draft bill authorizing proposals to allow scientists to use hybrid animal-human embryos for stem cell research and clarifying laws that allow the screening of embryos to produce babies with suitable bone marrow or other material for transplant to sick siblings

Trade Marks (Relative Grounds) Order 2007

  • Gowling Lafleur Henderson LLP
  • -
  • United Kingdom
  • -
  • March 14 2008

The UK Intellectual Property Office has adopted new examination rules that came into force on October 1, 2007

Clinical trial on gene therapy for blindness yields promising results

  • Gowling Lafleur Henderson LLP
  • -
  • United Kingdom
  • -
  • May 4 2009

On April 28, 2009, researchers from the Institute of Ophthalmology at University College London and Moorfields in the UK published the results from the world's first clinical trial to test the use of gene therapy to treat inherited blindness

New U.K. Life Sciences Super Cluster

  • Gowling Lafleur Henderson LLP
  • -
  • United Kingdom
  • -
  • February 12 2010

The U.K. government has recently announced their plans for a new U.K. Life Sciences Super Cluster - a scheme where industry, academia and the National Health Service work together to deliver new treatments for chronic disease

UK government launches "ACT on CO2" People Power Challenge initiative

  • Gowling Lafleur Henderson LLP
  • -
  • United Kingdom
  • -
  • December 15 2008

The UK Government's Department of Energy and Climate Change (DECC) has launched a program to challenge householders and drivers to save energy and cut back their carbon emissions

Current Search

Suggested Facets

Author

Jurisdiction

Workarea

© Copyright 2006-2013 Globe Business Publishing Ltd | Cookies | Disclaimer | Privacy policy